Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved Properties
- 1 April 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (4) , 1404-1413
Abstract
Daptomycin is a cyclic lipopeptide antibiotic approved for the treatment of skin and skin structure infections caused by Gram-positive pathogens and for that of bacteremia and right-sided endocarditis caused by Staphylococcus aureus . Daptomycin failed to meet noninferiority criteria for the treatment of community-acquired pneumonia, likely due to sequestration in pulmonary surfactant. Many analogues of daptomycin have been generated by combinatorial biosynthesis, but only two displayed improved activity in the presence of bovine surfactant, and neither was as active as daptomycin in vitro . In the present study, we generated hybrid molecules of the structurally related lipopeptide A54145 in Streptomyces fradiae and tested them for antibacterial activity in the presence of bovine surfactant. Hybrid A54145 nonribosomal peptide synthetase (NRPS) biosynthetic genes were constructed by genetic engineering and were expressed in combination with a deletion of the lptI methyltransferase gene, which is involved in the formation of the 3-methyl-glutamic acid (3mGlu) residue at position 12. Some of the compounds were very active against S. aureus and other Gram-positive pathogens; one compound was also highly active in the presence of bovine surfactant, had low acute toxicity, and showed some efficacy against Streptococcus pneumoniae in a mouse model of pulmonary infection.Keywords
This publication has 43 references indexed in Scilit:
- Genetic Analysis of Factors Affecting Susceptibility ofBacillus subtilisto DaptomycinAntimicrobial Agents and Chemotherapy, 2009
- Daptomycin: mechanisms of action and resistance, and biosynthetic engineeringCurrent Opinion in Chemical Biology, 2009
- Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane DepolarizationAntimicrobial Agents and Chemotherapy, 2008
- Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus CellsAntimicrobial Agents and Chemotherapy, 2007
- Structural Characterization of Daptomycin Analogues A21978C1-3(d-Asn11) Produced by a Recombinant Streptomyces roseosporus StrainJournal of Natural Products, 2007
- Combinatorial biosynthesis of novel antibiotics related to daptomycinProceedings of the National Academy of Sciences, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiaeJournal of Industrial Microbiology and Biotechnology, 2005
- Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporusJournal of Industrial Microbiology and Biotechnology, 2005